These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26034157)

  • 1. Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.
    Mills SD; Fox RS; Merz EL; Clements PJ; Kafaja S; Malcarne VL; Furst DE; Khanna D
    J Rheumatol; 2015 Sep; 42(9):1624-30. PubMed ID: 26034157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
    Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of the Body Concealment Scale for Scleroderma.
    Jewett LR; Malcarne VL; Kwakkenbos L; Harcourt D; Rumsey N; Körner A; Steele RJ; Hudson M; Baron M; Haythornthwaite JA; Heinberg L; Wigley FM; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1158-65. PubMed ID: 26663624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of English-French differential item functioning of the Satisfaction with Appearance Scale (SWAP) in systemic sclerosis.
    Jewett LR; Kwakkenbos L; Hudson M; Baron M; Thombs BD;
    Body Image; 2017 Sep; 22():97-102. PubMed ID: 28711486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort.
    Jewett LR; Kwakkenbos L; Carrier ME; Malcarne VL; Harcourt D; Rumsey N; Mayes MD; Assassi S; Körner A; Fox RS; Gholizadeh S; Mills SD; Fortune C; Portales A; Thombs BD;
    Body Image; 2017 Mar; 20():99-106. PubMed ID: 28068643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.
    Gholizadeh S; Mills SD; Fox RS; Merz EL; Roesch SC; Clements PJ; Kafaja S; Furst DE; Khanna D; Malcarne VL
    J Rheumatol; 2017 Jun; 44(6):795-798. PubMed ID: 28412704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Fox RS; Kwakkenbos L; Carrier ME; Mills SD; Gholizadeh S; Jewett LR; Roesch SC; Merz EL; Assassi S; Furst DE; Gottesman K; Mayes MD; Thombs BD; Malcarne VL;
    Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1646-1652. PubMed ID: 29409146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satisfaction With Appearance Scale-SWAP: Adaptation and validation for Brazilian burn victims.
    Caltran MP; Freitas NO; Dantas RA; Farina JA; Rossi LA
    Burns; 2016 Sep; 42(6):1331-9. PubMed ID: 27143340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cultural adaptation and validation of a Swedish version of the satisfaction with appearance scale (SWAP-Swe).
    Dahl O; Wickman M; Wengström Y
    Burns; 2014 Jun; 40(4):598-605. PubMed ID: 24080124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
    Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort.
    Harel D; Mills SD; Kwakkenbos L; Carrier ME; Nielsen K; Portales A; Bartlett SJ; Malcarne VL; Thombs BD;
    BMJ Open; 2019 Feb; 9(2):e024010. PubMed ID: 30798308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis.
    Baron M; Hudson M; Steele R; Lo E;
    J Rheumatol; 2011 Sep; 38(9):1925-30. PubMed ID: 21724704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis.
    Thombs BD; Hudson M; Schieir O; Taillefer SS; Baron M;
    Arthritis Rheum; 2008 Mar; 59(3):438-43. PubMed ID: 18311754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society.
    Taş YM; Derviş Hakim G; Keskinoğlu P; Kenar G; Yarkan H; Zengin B; Can G; Önen F; Akkoç N; Birlik M; Akarsu M
    Turk J Gastroenterol; 2019 Mar; 30(3):234-241. PubMed ID: 30541712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
    Merz EL; Kwakkenbos L; Carrier ME; Gholizadeh S; Mills SD; Fox RS; Jewett LR; Williamson H; Harcourt D; Assassi S; Furst DE; Gottesman K; Mayes MD; Moss TP; Thombs BD; Malcarne VL;
    BMJ Open; 2018 Mar; 8(3):e018641. PubMed ID: 29511009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Mills SD; Kwakkenbos L; Carrier ME; Gholizadeh S; Fox RS; Jewett LR; Gottesman K; Roesch SC; Thombs BD; Malcarne VL;
    Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1557-1562. PubMed ID: 29342510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis.
    Mattsson M; Hesselstrand R; Gunnarsson K; Dyrsmeds E; Holmner M; Nordin A; Boström C
    J Scleroderma Relat Disord; 2023 Feb; 8(1):53-63. PubMed ID: 36743814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study.
    Fox RS; Mills SD; Gholizadeh S; Merz EL; Roesch SC; Clements PJ; Kafaja S; Khanna D; Furst DE; Malcarne VL
    J Scleroderma Relat Disord; 2020 Jun; 5(2):143-151. PubMed ID: 35382027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale.
    Heinberg LJ; Kudel I; White B; Kwan A; Medley K; Wigley F; Haythornthwaite J
    Body Image; 2007 Mar; 4(1):79-86. PubMed ID: 18089254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.